JREU:SW:SW-JPM US Research Enhanced Index Equity ESG UCITS ETF USD acc (USD)

ETF | Others |

Last Closing

USD 53.07

Change

+0.16 (+0.30)%

Market Cap

N/A

Volume

0.05M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-21 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
CHSRIA:SW UBS ETF (CH) MSCI Switzerland ..

-0.20 (-0.99%)

USD 492,935.36B
XLDX:SW Xtrackers LevDAX Daily Swap UC..

-2.10 (-1.26%)

USD 411,075.38B
CHSRI:SW UBS ETF (CH) - MSCI Switzerlan..

-0.11 (-0.63%)

USD 368,190.74B
XNIF:SW Xtrackers Nifty 50 Swap UCITS ..

+1.70 (+0.70%)

USD 292,109.69B
SWICHA:SW UBS ETF (CH) – MSCI Switzerl..

-0.17 (-0.77%)

USD 226,274.25B
SWUSAH:SW UBS ETF (CH) – MSCI Switzerl..

-0.13 (-0.47%)

USD 226,274.21B
SWEUAH:SW UBS ETF (CH) – MSCI Switzerl..

N/A

USD 226,274.20B
RGLDS:SW Raiffeisen ETF Solid Gold A US..

+177.00 (+2.52%)

USD 134,034.93B
RGLDSH:SW Raiffeisen ETF Solid Gold H CH..

-48.50 (-1.01%)

USD 134,034.91B
RGLDOH:SW Raiffeisen ETF Solid Gold Ounc..

-23.20 (-1.54%)

USD 134,034.86B

ETFs Containing JREU:SW

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.88% 70% C- 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.88% 70% C- 71% C-
Trailing 12 Months  
Capital Gain 30.20% 90% A- 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 30.20% 90% A- 90% A-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 8.33% 87% B+ 85% B
Dividend Return 8.33% 87% B+ 85% B
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.09% 22% F 30% F
Risk Adjusted Return 63.59% 92% A 92% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.